Login / Register Order My Items
mob-logo
Contact Us
800.227.0627
Contact Us Quote Order Login / Register

PACE Phosphonoacetate Oligonucleotide Modification

Advanced backbone engineering for therapeutic oligonucleotides. Bio-Synthesis provides custom PACE phosphonoacetate oligo modification support for ASO, gapmer, siRNA, splice-switching oligonucleotide, and RNA-targeting therapeutic applications.

PACE Backbone Phosphonoacetate Linkage ASO / Gapmer siRNA SSO PK Optimization Nuclease Resistance Therapeutic Oligos
Request a Quote Speak to a Scientist
Talk to a chemist Request a quote
Overview Mechanism PACE vs PO Gapmer architecture Advantages Applications Chemistry comparison Synthesis options FAQ Contact

PACE Oligonucleotide Overview

PACE phosphonoacetate oligonucleotide modification is an advanced backbone chemistry strategy used to tune the biological performance of therapeutic oligonucleotides. PACE linkages can be incorporated into oligo backbones to influence nuclease resistance, charge distribution, protein interactions, pharmacokinetics, biodistribution, and tolerability.

Unlike sugar modifications such as LNA, BNA, 2′-MOE, or cEt that primarily increase target-binding affinity, PACE chemistry is focused on backbone-level pharmacological optimization. This makes it useful for advanced ASO, gapmer, siRNA, splice-switching oligonucleotide, and RNA therapeutic development programs.

PACE-modified oligonucleotides may be designed as fully modified or mixed-linkage constructs, depending on the target mechanism, delivery strategy, tissue distribution goals, and compatibility with RNase H or RNAi activity.

Definition: PACE phosphonoacetate oligonucleotide modification is a backbone engineering strategy that introduces phosphonoacetate linkages to tune oligonucleotide stability, pharmacokinetics, biodistribution, protein interactions, and tolerability.

PACE Backbone Benefits

Enhanced nuclease resistance

Improved stability in biological fluids and protection against nuclease degradation.

Improved pharmacokinetics

Longer serum persistence, improved exposure, and extended target engagement.

Reduced protein binding

Lower nonspecific interactions and reduced plasma protein sequestration.

Optimized biodistribution

Better tissue exposure and organ-targeting potential for therapeutic oligos.

Tunable safety profile

Backbone engineering may improve tolerability and reduce toxicity risk.

Key Applications

Gapmer ASOs

RNase H-mediated RNA knockdown and therapeutic gene silencing.

Antisense oligonucleotides

mRNA modulation, splice control, exon skipping, and transcript targeting.

siRNA duplexes

Improved stability, duration, and pharmacokinetic performance.

SSOs & aptamers

Enhanced stability, binding behavior, and functional RNA modulation.

Therapeutic platforms

Broad utility across liver, CNS, immune, oncology, and extrahepatic targets.

PK Tuning

PACE chemistry can be used to tune systemic exposure, tissue distribution, serum persistence, and drug-like behavior.

Backbone Engineering

Phosphonoacetate linkages provide an additional design lever beyond standard phosphodiester and phosphorothioate chemistries.

Therapeutic Design

PACE-modified oligos can support ASO, gapmer, siRNA, SSO, and advanced RNA therapeutic research.

Custom Synthesis

Bio-Synthesis supports customized oligonucleotide modification workflows, purification, QC, and development-scale manufacturing.

PACE Backbone Mechanism

PACE modification overview: PACE linkages can tune backbone charge behavior, nuclease resistance, protein interactions, pharmacokinetics, and tissue distribution in therapeutic oligonucleotide designs.

PACE phosphonoacetate chemistry modifies the oligonucleotide backbone by introducing phosphonoacetate-containing linkages. These linkage-level changes influence how an oligonucleotide interacts with nucleases, serum proteins, cellular uptake pathways, and tissue environments.

PACE Phosphonoacetate Backbone Engineering Workflow

PACE phosphonoacetate oligonucleotide modification schematic showing backbone engineering, nuclease resistance, pharmacokinetic optimization, biodistribution tuning, and therapeutic oligo development
Why Choose Bio-Synthesis for PACE Oligonucleotide Development? Bio-Synthesis supports advanced therapeutic oligonucleotide programs with expertise in backbone engineering, custom oligonucleotide chemistry, analytical characterization, purification, conjugation strategies, and scalable synthesis workflows for ASO, gapmer, siRNA, and RNA-targeting applications.

Design note: Placement, number, and spacing of PACE linkages should be selected based on target mechanism, oligo modality, desired PK profile, toxicity considerations, and whether RNase H or RNAi activity must be preserved.

PACE vs Phosphodiester Backbone

PACE vs Phosphodiester Backbone
Feature Phosphodiester (PO) PACE Backbone Design Impact
Nuclease Resistance Moderate High Improves biological stability
Protein Binding Higher Lower May reduce nonspecific interactions
PK / Half-life Shorter Longer Supports longer target exposure
Charge Density Higher Lower Can alter uptake and distribution
Flexibility Higher Reduced Changes duplex behavior
RNase H Activity High Maintained* Depends on gap placement
Toxicity Potential Higher Lower May improve therapeutic index
Clinical Potential Established Next Generation Useful for advanced optimization
Design note: PACE is best positioned as a next-generation backbone engineering strategy for tuning oligonucleotide stability, pharmacokinetics, biodistribution, protein interaction, and tolerability. RNase H compatibility depends on sequence context, gap design, and placement of PACE linkages.

PACE Gapmer and ASO Architecture

PACE chemistry can be incorporated into ASO and gapmer designs to tune backbone performance while preserving target recognition and, when required, RNase H compatibility.

Component Design Role PACE Integration Strategy Why It Matters
Modified Wings Increase affinity and nuclease resistance PACE may be paired with LNA, BNA, 2′-MOE, cEt, or 2′-OMe wings Improves stability and target engagement
Central DNA Gap Supports RNase H1 recognition in gapmers PACE placement should preserve RNase H-compatible duplex geometry Critical for RNA cleavage activity
Backbone Linkages Control nuclease resistance, protein binding, and PK PACE can be used in partial or patterned linkage designs Enables backbone-level pharmacology tuning
Conjugation Site Supports delivery, targeting, or detection PACE can be combined with GalNAc, cholesterol, lipid, peptide, biotin, or fluorophore strategies Improves application-specific functionality

Advantages of PACE Oligonucleotide Modification

Improved Pharmacokinetic Tuning

  • Can support extended systemic exposure
  • May alter clearance and tissue distribution
  • Useful for drug-like oligonucleotide optimization
  • Can be integrated into mixed-backbone designs

Enhanced Nuclease Resistance

  • Can reduce enzymatic degradation
  • Supports biological persistence
  • May improve serum stability
  • Useful for in vivo oligonucleotide research

Tunable Protein Interactions

  • Backbone chemistry affects plasma protein binding
  • Can influence tissue uptake and exposure
  • May reduce unwanted nonspecific interactions
  • Important for high-dose therapeutic oligos

Potential Tolerability Benefits

  • Can help optimize therapeutic index
  • May reduce toxicity risk in selected designs
  • Supports chronic dosing optimization
  • Useful in preclinical candidate refinement

Applications of PACE-Modified Oligonucleotides

ASO Therapeutics

PACE chemistry can be used in antisense oligonucleotide programs for RNA knockdown, target validation, and therapeutic candidate optimization.

  • mRNA knockdown
  • lncRNA targeting
  • Preclinical ASO development
  • Mixed-backbone optimization

Gapmer ASOs

PACE can be integrated into gapmer designs to tune stability, RNase H compatibility, PK, and tolerability.

  • RNase H-compatible design
  • Modified wing strategies
  • PS/PACE mixed linkage
  • Target RNA degradation

siRNA and RNAi

PACE-modified RNAi constructs may support serum stability, delivery-system compatibility, and in vivo persistence.

  • siRNA optimization
  • LNP compatibility
  • Ligand-conjugated RNA
  • Stability tuning

Splice-Switching Oligos

PACE chemistry may support splice modulation programs requiring improved stability and biological persistence.

  • Exon skipping
  • Exon inclusion
  • Pre-mRNA targeting
  • Rare disease research

Advanced Oligonucleotide Chemistry Comparison

PACE is most powerful when positioned as part of a broader modification toolbox that includes backbone, sugar, base, terminal, and conjugation chemistries.

Chemistry / Modification Type Key Advantage Best Applications Notes
PACE Phosphonoacetate Backbone/linkage Tunes charge behavior, PK, protein binding, and stability Advanced ASO, gapmer, siRNA, and SSO optimization Useful for mixed-backbone designs
Phosphorothioate (PS) Backbone Improves nuclease resistance and exposure ASO and gapmer designs Industry-standard backbone
LNA / BNA Bridged sugar Very high target affinity and potency Gapmer wings and short ASO designs Placement and spacing matter
2′-MOE Sugar Improves stability, affinity, and tolerability Therapeutic-style ASO wings Widely used in ASO development
cEt Constrained sugar analog High affinity and structural control Advanced gapmer designs Useful for potent ASO optimization
GalNAc Conjugate Liver-targeted delivery Hepatic targets and metabolic disease research Can pair with backbone optimization
Cholesterol / Lipid Conjugate Membrane interaction and biodistribution tuning Systemic delivery and preclinical studies Application-specific optimization
Peptide Conjugate Conjugate Cell penetration and tissue targeting Extrahepatic delivery research Customizable targeting option

Need a specialized PACE oligonucleotide design?

Bio-Synthesis supports customized base, sugar, backbone, terminal, and conjugation modifications. Contact us or request a quote for custom PACE oligo synthesis.

Custom PACE Oligonucleotide Synthesis Options

Bio-Synthesis offers flexible PACE oligonucleotide modification support for discovery, translational research, and preclinical therapeutic oligonucleotide programs.

Design & Chemistry

  • PACE phosphonoacetate backbone modification
  • ASO, gapmer, siRNA, SSO, and mixed-backbone designs
  • Compatibility with PS, PO, LNA, BNA, MOE, cEt, and custom chemistries
  • Advanced conjugation and delivery optimization support

Scale & Purification

  • Research to development-scale synthesis
  • HPLC and PAGE purification options
  • Desalting, salt exchange, lyophilization, and formulation support
  • Custom project review for challenging sequences

Quality Control

  • Mass spectrometry confirmation
  • Analytical HPLC
  • OD260 quantification
  • Custom release testing upon request

Quality System Support

  • ISO 9001:2015 / ISO 13485:2016
  • GLP/GMP-aligned project support
  • U.S.A. facilities in Texas
  • Therapeutic oligonucleotide manufacturing experience

FAQ

What is PACE phosphonoacetate oligonucleotide modification?

PACE modification is an advanced backbone chemistry where phosphonoacetate linkages are incorporated into the oligonucleotide backbone to improve stability, pharmacokinetics, biodistribution, and therapeutic performance.

What are the benefits of PACE-modified oligonucleotides?

PACE modifications may improve nuclease resistance, systemic stability, tissue exposure, protein-binding behavior, tolerability, and overall therapeutic pharmacology.

Is PACE compatible with gapmer ASOs?

Yes. PACE chemistry can be incorporated into gapmer ASO designs alongside phosphorothioate, LNA, BNA, 2′-MOE, cEt, and other modifications. Placement should be optimized to preserve RNase H activity.

Can PACE be combined with GalNAc or lipid conjugation?

Yes. PACE-modified oligonucleotides may be combined with GalNAc, cholesterol, lipid, peptide, biotin, fluorophore, or other conjugation strategies depending on the target application.

More FAQ'sAll FAQ's

Contact & Quote Request

For the fastest review, send your target sequence, oligo modality, preferred backbone design, PACE placement goals, scale, purification, QC requirements, and any conjugation or delivery needs.

Fast quote checklist

  • Sequence and target transcript or gene
  • Modality: ASO, gapmer, siRNA, SSO, or custom
  • Preferred chemistry: PACE, PS, LNA, BNA, MOE, cEt, GalNAc, lipid, or custom
  • Scale, purity, and QC requirements
  • Conjugation, labeling, or documentation needs

Fastest path

Request a Quote Speak to a Scientist

Scientific Validation & Recommended Reading

PACE phosphonoacetate backbone chemistry should be discussed within the broader scientific context of therapeutic oligonucleotide backbone engineering, ASO pharmacology, RNase H activity, nuclease resistance, and delivery optimization.

Why Choose Bio-Synthesis

Trusted by biotech leaders worldwide for over 45+ years of delivering high quality, fast and scalable synthetic biology solutions.

Greetings Researchers,

Please be advised that any information, guidelines, writeups, and oral/video/graphic content on our website are intended solely as general guidelines.
It is the researcher's sole responsibility to conduct thorough research on the designs of the products intended for their experiments before submitting
their designs to Biosynthesis for review of production feasibility.
Thank you for your understanding.

Quick Links